Astrazeneca Pharmaceuticals

By issue

• Medicare and Medicaid$3.8M · 36 reports
• Health issues$3.4M · 31 reports
• Pharmacy$2.9M · 18 reports
• Copyright, patent and trademark$2.8M · 15 reports
• Taxation$2.8M · 15 reports
• Tariffs$1.2M · 5 reports
• Trade$748.4K · 4 reports
• Budget and appropriations$421.3K · 3 reports
• Insurance$411K · 3 reports
• Labor, antitrust and workplace$327K · 2 reports
• Clean air and water$230K · 4 reports
• Environment and Superfund$117K · 1 reports
• Medical research and clinical labs$117K · 1 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

• HOUSE OF REPRESENTATIVES37 reports
• SENATE30 reports
• Centers For Medicare and Medicaid Services (CMS)18 reports
• White House Office15 reports
• Food & Drug Administration (FDA)9 reports
• Health & Human Services, Dept of (HHS)7 reports
• U.S. Trade Representative (USTR)6 reports
• Commerce, Dept of (DOC)4 reports
• Council on Environmental Quality (CEQ)4 reports
• Agriculture, Dept of (USDA)3 reports
• Energy, Dept of3 reports
• Health Resources & Services Administration (HRSA)3 reports
• Bureau of Industry and Security (BIS)2 reports
• Intl Trade Administration (ITA)2 reports
• Labor, Dept of (DOL)1 reports
• Office of Management & Budget (OMB)1 reports
• State, Dept of (DOS)1 reports
• Treasury, Dept of1 reports